CRB expansion
Cleveland-based chemical synthesis specialist Cambridge Research Biochemicals is embarking on a £100,000 project to expand its production facilities.
based chemical synthesis specialist Cambridge Research Biochemicals (
) is embarking on a £100,000 project to expand its production facilities.
The investment, which includes a £34,000 grant for business investment from regional development agency One North East, will go towards buying a chemical synthesiser to produce peptides for academic and industrial drug discovery research.
The apparatus will increase the volume of peptides manufactured each year and allow enhanced peptide synthesis, which can produce hundreds of peptides simultaneously on a sub-micro scale. The company will recruit two chemists to support this activity.
CRB’s customers include pharmaceutical companies Pfizer, GlaxoSmithKline and AstraZeneca and the research company is seeking to increase its share in the academic sector.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of premium content. Register for free to unlock unlimited access to all of our premium content, as well as the latest technology news, industry opinion and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
I´m sure politicians will be thumping tables and demanding answers - while Professor Bell, as reported above, says ´wait for detailed professional...